Last updated on January 2019

An Open-Label Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Pulmonary Arterial Hypertension
  • Age: Between 18 - 75 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Participated in United Therapeutics Study TDE-PH-310

Exclusion Criteria:

  • Premature discontinuation of United Therapeutics Study TDE-PH-310 due to reasons other than clinical worsening

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.